Telemedicine – Policy & Medicine

HHS Endorses Telehealth Accreditation Programs

Stakeholders Urge DEA to Take Action to Extend Telemedicine Prescribing Flexibilities

DEA and HHS Extend Telehealth Flexibilities for Controlled Substances

ATA Action Outlines Recommendations for DEA Telemedicine Special Registration Process

Telemedicine Leads to Fewer Follow-Up Visits When Compared to In-Person Visits

DEA Seeking Input on Prescribing Controlled Substances via Telemedicine

HIPAA Enforcement Discretion Ends as Part of COVID Public Health Emergency Ending

HHS OIG Releases Telehealth HHS OIG Toolkit

DEA Announces Extension of Telemedicine Flexibilities, Despite PHE Ending

The Impact of Ending the Public Health Emergency on Telemedicine